MAL20076027AZPrescription (MAL-A)

Xbira 250mg (Abiraterone Acetate Tablets USP 250mg)

Generic Molecule: Abiraterone Acetate

ACTIVE & APPROVEDValid till: 10 Jul 2030
NPRA Official Regulatory Summary

Xbira 250mg (Abiraterone Acetate Tablets USP 250mg) is a KKM-approved Prescription Medicine registered under MAL number MAL20076027AZ by CIPLA MALAYSIA SDN BHD. Its active ingredient is Abiraterone Acetate 250 mg 710 mg, manufactured by Aizant Drug Research Solutions Private Limited.

Holder (PRH)
CIPLA MALAYSIA SDN BHD
Manufacturer
Aizant Drug Research Solutions Private Limited
First Registered
10 Jul 2025
Validity
10 Jul 2030

Prescription Required (Schedule Poison)

Need a valid doctor's prescription renewal in Malaysia?

Consult Online Doctor (Telehealth)

Active Ingredients & Strength Formulation

1 Component
Active Substance / MoleculeDeclared Strength / DosageGeneric Directory
Abiraterone Acetate250 mg 710 mgFind Brands
Dosage values indicate declared active concentration per unit dose as registered with NPRA Malaysia.

Malaysian KKM Security Hologram Verification

FarmaChecker & Meditag™

By Malaysian Ministry of Health (KKM) regulation, all genuine registered pharmaceuticals, health supplements (MAL-N), and traditional products (MAL-T) distributed in Malaysia must feature an official tamper-evident security hologram sticker on the physical packaging.

1. Visual Tilt Check

Tilt the box under light to view the micro-engraved KKM coat of arms and multi-layer iridescent security patterns.

2. Match MAL Number

Ensure the printed MAL code matches MAL20076027AZ exactly on label and box.

3. FarmaChecker Scan

Scan using the official FarmaChecker app on iOS / Android to authenticate serial token with NPRA servers.

If the packaging lacks a security hologram or fails the FarmaChecker scan, do not consume and report to Cawangan Penguatkuasaan Farmasi (CPF KKM).
Frequently Asked Questions & Verification Details

Is Xbira 250mg (Abiraterone Acetate Tablets USP 250mg) approved by KKM / NPRA?

Yes. Xbira 250mg (Abiraterone Acetate Tablets USP 250mg) is actively registered with the National Pharmaceutical Regulatory Agency under official registration number MAL20076027AZ with current status PRODUCT APPROVED. Registration was filed by CIPLA MALAYSIA SDN BHD.

What are the active ingredients of Xbira 250mg (Abiraterone Acetate Tablets USP 250mg)?

The declared active therapeutic components are: Abiraterone Acetate 250 mg 710 mg. Always follow dosage recommendations prescribed by a certified doctor or licensed pharmacist.

What are the registered generic alternatives in Malaysia?

In Malaysia, there are 10 registered brand formulations containing identical active ingredients (Abiraterone Acetate). You can review them in the alternative brands section above or consult your community pharmacist for generic bioequivalent substitution.

Semakan status pendaftaran KKM / NPRA: Xbira 250mg (Abiraterone Acetate Tablets USP 250mg) (MAL20076027AZ) | Pengganti ubat di Malaysia | Bahan aktif ubat & maklumat farmasi.